Glutaminases regulate glutathione and oxidative stress in cancer

Area of Science:

• Oncology
• Cancer Metabolism
• Drug Resistance

Background:

• Targeted cancer therapies face resistance due to metabolic rewiring.
• Resistant cancer cells exhibit enhanced antioxidant capacity via glutathione, NRF2 activation, and antioxidant gene overexpression.
• This metabolic adaptation alters the tumor microenvironment and cellular redox balance.

Purpose of the Study:

• To review novel synergistic approaches combining glutaminase inhibition and redox-dependent modulation for cancer therapy.
• To explore strategies for overcoming therapeutic resistance driven by metabolic adaptation.
• To provide insights into rational combination strategies for improved cancer treatment outcomes.

Main Methods:

• Review of literature on cancer metabolism, targeted therapy resistance, and redox biology.
• Analysis of the role of glutaminases in cancer cell metabolism and survival.
• Discussion of synergistic therapeutic strategies involving glutaminase inhibition and oxidative stress modulation.

Main Results:

• Cancer cells upregulate antioxidant pathways, including glutathione synthesis and NRF2 activation, to survive oxidative stress induced by therapies.
• Glutaminase isoenzymes play context-dependent roles in cancer, influencing oxidative phosphorylation and redox status.
• Glutamine and glutamate act as signaling molecules regulating redox and bioenergetic pathways.

Conclusions:

• Combination strategies involving glutaminase inhibition and redox modulation show promise for overcoming cancer therapy resistance.
• Targeting glutaminolysis and antioxidant pathways simultaneously can disrupt cancer cell homeostasis.
• Pharmacological or genetic regulation of glutaminase combined with oxidative chemotherapy offers a potential path to enhance therapeutic success.